120 related articles for article (PubMed ID: 1683547)
1. Distribution and elimination of [2-14C]amino-3,8-dimethylimidazo [4, 5-f] quinoxaline in mice. Analysis by whole animal autoradiography.
Gooderham NJ; Soames A; Rice JC; Boobis AR; Davies DS
Hum Exp Toxicol; 1991 Sep; 10(5):337-45. PubMed ID: 1683547
[TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of the food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rats.
Sjödin P; Wallin H; Alexander J; Jägerstad M
Carcinogenesis; 1989 Jul; 10(7):1269-75. PubMed ID: 2661045
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in two strains of male rats.
Tjøtta K; Ingebrigtsen K; Aune T
Carcinogenesis; 1992 May; 13(5):779-82. PubMed ID: 1586989
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the food-borne mutagen/carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat: assessment of biliary metabolites for genotoxicity.
Turesky RJ; Aeschbacher HU; Malnoë A; Würzner HP
Food Chem Toxicol; 1988 Feb; 26(2):105-10. PubMed ID: 3366409
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates.
Snyderwine EG; Welti DH; Davis CD; Fay LB; Turesky RJ
Carcinogenesis; 1995 Jun; 16(6):1377-84. PubMed ID: 7788858
[TBL] [Abstract][Full Text] [Related]
6. Distribution of radiolabelled [2-14C]IQ and MeIQx in the mouse.
Alldrick AJ; Rowland IR
Toxicol Lett; 1988 Nov; 44(1-2):183-90. PubMed ID: 3188077
[TBL] [Abstract][Full Text] [Related]
7. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.
Lynch AM; Knize MG; Boobis AR; Gooderham NJ; Davies DS; Murray S
Cancer Res; 1992 Nov; 52(22):6216-23. PubMed ID: 1423264
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans.
Turesky RJ; Garner RC; Welti DH; Richoz J; Leveson SH; Dingley KH; Turteltaub KW; Fay LB
Chem Res Toxicol; 1998 Mar; 11(3):217-25. PubMed ID: 9544620
[TBL] [Abstract][Full Text] [Related]
9. Covalent binding of [2-14C]2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) to mouse DNA in vivo.
Alldrick AJ; Lutz WK
Carcinogenesis; 1989 Aug; 10(8):1419-23. PubMed ID: 2665966
[TBL] [Abstract][Full Text] [Related]
10. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
[TBL] [Abstract][Full Text] [Related]
11. Effects of enzyme induction on the distribution of the food carcinogen 2-amino-3,8-dimethyl-imidazo[4,5-ss]-quinoxaline (MeIQx) in Ah-receptor- responsive- and Ah-receptor-non-responsive mice.
Vikse R; Ingebrigtsen K; Klungsøyr L; Alexander J
Pharmacol Toxicol; 1995 Jul; 77(1):57-64. PubMed ID: 8532613
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the mutagen MeIQx in vivo: metabolite screening by liquid chromatography-thermospray mass spectrometry.
Gooderham NJ; Watson D; Rice JC; Murray S; Taylor GW; Davies DS
Biochem Biophys Res Commun; 1987 Nov; 148(3):1377-82. PubMed ID: 3689400
[TBL] [Abstract][Full Text] [Related]
13. Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat.
Turesky RJ; Aeschbacher HU; Würzner HP; Skipper PL; Tannenbaum SR
Carcinogenesis; 1988 Jun; 9(6):1043-8. PubMed ID: 3370749
[TBL] [Abstract][Full Text] [Related]
14. Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.
Malfatti MA; Kuhn EA; Turteltaub KW; Vickers SM; Jensen EH; Strayer L; Anderson KE
Chem Res Toxicol; 2016 Mar; 29(3):352-8. PubMed ID: 26918625
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-14C-labeled MeIQx) in rats.
Sjödin P; Nyman M; Nielsen LL; Wallin H; Jägerstad M
Nutr Cancer; 1992; 17(2):139-51. PubMed ID: 1316601
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.
Stillwell WG; Kidd LC; Wishnok JS; Tannenbaum SR; Sinha R
Cancer Res; 1997 Aug; 57(16):3457-64. PubMed ID: 9270013
[TBL] [Abstract][Full Text] [Related]
17. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
18. N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine.
Stillwell WG; Turesky RJ; Sinha R; Tannenbaum SR
Cancer Res; 1999 Oct; 59(20):5154-9. PubMed ID: 10537291
[TBL] [Abstract][Full Text] [Related]
19. Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Lakshmi VM; Hsu FF; Schut HA; Zenser TV
Chem Res Toxicol; 2006 Feb; 19(2):325-33. PubMed ID: 16485910
[TBL] [Abstract][Full Text] [Related]
20. Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin.
Lynch AM; Murray S; Zhao K; Gooderham NJ; Boobis AR; Davies DS
Carcinogenesis; 1993 Feb; 14(2):191-4. PubMed ID: 8435859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
